Crossmark

Baxdrostat for the treatment of primary aldosteronism: current evidence

Crossref DOI link: https://doi.org/10.1007/s12020-026-04570-2

Published Online: 2026-03-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Menino, João https://orcid.org/0009-0002-3594-7061
Vega, Arturo

Goi, Jessica

Araujo-Castro, Marta https://orcid.org/0000-0002-0519-0072
License Information

Text and Data Mining valid from 2026-03-11

Version of Record valid from 2026-03-11
More Information

Article History

Received: 2 December 2025

Accepted: 24 January 2026

First Online: 11 March 2026

Declarations

:

: The authors declare no competing interests.